Collegium Pharmaceutical Inc (COLL)

Receivables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 631,449 599,245 576,653 566,923 566,767 546,642 536,946 524,949 463,933 361,675 313,505 272,898 276,868 325,777 326,110 321,226 310,016 307,948 301,714 298,696
Receivables US$ in thousands
Receivables turnover

December 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $631,449K ÷ $—K
= —

The receivables turnover ratio for Collegium Pharmaceutical Inc is not provided in the available data spanning from March 31, 2020, to December 31, 2024. The receivables turnover ratio is a financial metric that indicates how efficiently a company is collecting on its credit sales during a specific period.

The absence of data for the receivables turnover ratio in this case limits our ability to assess the company's effectiveness in managing its accounts receivable and collecting payments from customers. A higher turnover ratio generally indicates that the company is efficiently collecting payments on its credit sales, while a low ratio may suggest inefficiencies or potential collection issues.

In order to conduct a more comprehensive analysis of Collegium Pharmaceutical Inc's receivables turnover, it would be necessary to obtain the specific accounts receivable and sales figures for the corresponding periods to calculate the turnover ratio. This calculation involves dividing the net credit sales by the average accounts receivable balance for the period under consideration. Such analysis would provide insights into the company's credit policies, collection procedures, and overall liquidity management.